leisure time -WSS

leisure time

author：fashion 2025-09-28 01:30:44 - browse：8335

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why Marc Tessier

hotspot

WSS

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Insurer loopholes limit power of law against surprise medical bills

How Brent Saunders' Allergan experiment failed

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

focus

leisure time

focus

In Memoriam: Notable people who died in 2023

U.K. decision on ALS drug has neurologists, advocates up in arms

Hepatitis C has a cure — but many Americans still lack access to it

What is artificial intelligence? Experts weigh in

Bright Health sells Medicare Advantage business to Molina

Hey, doctors: Don't be no

Hollywood unions extend contract negotiations for actors

Pfizer's RSV vaccine recommended for approval in Europe

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

focus

Young boy dies in trial for Pfizer Duchenne gene therapy

Pfizer's RSV vaccine recommended for approval in Europe

Harvard scientists, with Google, unveil the most detailed brain map ever

What is artificial intelligence? Experts weigh in

New chief aims to remake Sanofi Genzyme

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

entertainment

focus

hotspot

explore